|
[Related PubMed/MEDLINE] Total Number of Papers: 25
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Alterations of selected serum biochemical and urinary parameters in dogs with chronic enteropathy. |
ALB, CE, MCS, PLE, UPC |
2 |
2022 |
Complete Blood Count-Derived Inflammatory Markers Changes in Dogs with Chronic Inflammatory Enteropathy Treated with Adipose-Derived Mesenchymal Stem Cells. |
Ad-MSCs, CIE, NLR, PLR, SII |
3 |
2022 |
Investigating fecal microbial transplant as a novel therapy in dogs with inflammatory bowel disease: A preliminary study. |
FMT, IBD |
4 |
2022 |
Machine Learning and Canine Chronic Enteropathies: A New Approach to Investigate FMT Effects. |
CE, FMT |
5 |
2021 |
Clinical efficacy of prebiotics and glycosaminoglycans versus placebo In dogs with food responsive enteropathy receiving a hydrolyzed diet: A pilot study. |
FRD, GAGs, RCCT |
6 |
2021 |
Detection of Anti-Erythrocyte Antibodies in Dogs with Inflammatory Bowel Disease (IBD). |
IBD |
7 |
2021 |
Evaluation of duodenal endoscopic and histologic findings, including counts of forkhead box P3-positive regulatory T cells, in dogs with immunosuppressant-responsive enteropathy. |
IRE |
8 |
2021 |
Gastric mucosal pathology in Belgian Shepherd dogs with and without clinical signs of gastric disease. |
BSD, GC, GER |
9 |
2021 |
Platelet abnormalities and platelet-to-lymphocyte ratios in canine immunosuppressant-responsive and non-responsive enteropathy: A retrospective study in 41 dogs. |
IRE, MPV, PLR, PLT |
10 |
2021 |
Upregulation of signal transducer and activator of transcription 3 in dogs with chronic inflammatory enteropathies. |
CE, CIE, CO, FRE, IBD, p-STAT3, PLE, SRE, VLP |
11 |
2020 |
Clinical characteristics of dogs with food-responsive protein-losing enteropathy. |
AUC, CI, FR-PLE, IR-PLE, NR-PLE, PLE, ULFD |
12 |
2020 |
Neutrophil-to-Lymphocyte Ratio (NLR) in Canine Inflammatory Bowel Disease (IBD). |
CG, IBD, LD, NLR |
13 |
2020 |
Rapid Resolution of Large Bowel Diarrhea after the Administration of a Combination of a High-Fiber Diet and a Probiotic Mixture in 30 Dogs. |
DI |
14 |
2020 |
Serum amino acid profile in 51 dogs with immunosuppressant-responsive enteropathy (IRE): a pilot study on clinical aspects and outcomes. |
AAs, CD, Glu, His, IRE, Phe, PLE, SER, Trp, Tyr |
15 |
2019 |
Ki-67/CD3 ratio in the diagnosis of chronic inflammatory enteropathy in dogs. |
CD3, CIE, CO, IQR, LP |
16 |
2019 |
Plasma amino acid profiles in dogs with inflammatory bowel disease. |
CRP, IBD, WSAVA |
17 |
2019 |
Platelet indices as biomarkers for characterization and determination of severity in canine chronic enteropathy. |
--- |
18 |
2018 |
Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies. |
CIE, CR, CRP, PR |
19 |
2018 |
Correlating Gastrointestinal Histopathologic Changes to Clinical Disease Activity in Dogs With Idiopathic Inflammatory Bowel Disease. |
CIBDAI, IBD, LP |
20 |
2017 |
Clinicopathologic and prognostic factors in short- and long-term surviving dogs with protein-losing enteropathy. |
PLE, ROC |
21 |
2016 |
Does canine inflammatory bowel disease influence gut microbial profile and host metabolism? |
IBD, SCFA |
22 |
2015 |
Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes. |
ASC, CIBDAI, CRP, IBD, MSCs |
23 |
2014 |
Urinary and faecal N-methylhistamine concentrations do not serve as markers for mast cell activation or clinical disease activity in dogs with chronic enteropathies. |
CE, IS, NMH |
24 |
2013 |
Fecal calprotectin concentrations in adult dogs with chronic diarrhea. |
--- |
25 |
2011 |
CD11c+ cells are significantly decreased in the duodenum, ileum and colon of dogs with inflammatory bowel disease. |
DCs, IBD |
|